AERIE PHARMACEUTICALS INC Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Description of the Registrant's Securities (Filed With SEC on February 25, 2022)
- Letter Agreement, dated as of September 20, 2021, by and between Aerie Pharmaceuticals, Inc. and Benjamin F. McGraw, III, Pharm.D (Filed With SEC on November 5, 2021)
- Description of the Registrant's Securities (Filed With SEC on February 26, 2021)
- Amendment to Aerie Pharmaceuticals, Inc. Second Amended & Restated Inducement Award Plan (Filed With SEC on February 24, 2020)
- Description of the Registrants Securities (Filed With SEC on February 24, 2020)
- Form of Additional Capped Call Transaction Confirmation (Filed With SEC on September 13, 2019)
- Form of Capped Call Transaction Confirmation (Filed With SEC on September 10, 2019)
- AERIE PHARMACEUTICALS, INC. INDUCEMENT AWARD PLAN (Effective as of December 7, 2016) (Filed With SEC on March 9, 2017)
- AERIE PHARMACEUTICALS, INC. 106 Glenhaven Drive Chapel Hill,North Carolina 27516 July 29, 2005 (Filed With SEC on October 3, 2013)
- AERIE PHARMACEUTICALS, INC. 135 US Highway 206, Suite 9 Bedminster, NJ 07921 December 15, 2011 (Filed With SEC on October 3, 2013)
- AERIE PHARMACEUTICALS, INC. 135 US Highway 206, Suite 15 Bedminster, NJ 07921 September 24, 2012 (Filed With SEC on October 3, 2013)
